Page last updated: 2024-09-03

garenoxacin and Long QT Syndrome

garenoxacin has been researched along with Long QT Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chinushi, M; Nakamura, Y; Ochiai, S; Sato, A; Tagawa, M	1

Other Studies

1 other study(ies) available for garenoxacin and Long QT Syndrome

Article	Year
Secondly ECG recordings in the emergency room revealed Garenoxacin-induced abnormal QT interval prolongation in a patient with multiple syncopal attacks. Heart and vessels, 2016, Volume: 31, Issue:7 Topics: Adrenergic Agonists; Adrenergic beta-1 Receptor Antagonists; Aged; Anti-Bacterial Agents; Electrocardiography; Emergency Service, Hospital; Epinephrine; ERG1 Potassium Channel; Exercise Test; Female; Fluoroquinolones; Genetic Predisposition to Disease; Heart Rate; Humans; Long QT Syndrome; Metoprolol; Mutation; Phenotype; Predictive Value of Tests; Recurrence; Risk Factors; Syncope	2016

Article

Year

Secondly ECG recordings in the emergency room revealed Garenoxacin-induced abnormal QT interval prolongation in a patient with multiple syncopal attacks.

Heart and vessels, 2016, Volume: 31, Issue:7

Topics: Adrenergic Agonists; Adrenergic beta-1 Receptor Antagonists; Aged; Anti-Bacterial Agents; Electrocardiography; Emergency Service, Hospital; Epinephrine; ERG1 Potassium Channel; Exercise Test; Female; Fluoroquinolones; Genetic Predisposition to Disease; Heart Rate; Humans; Long QT Syndrome; Metoprolol; Mutation; Phenotype; Predictive Value of Tests; Recurrence; Risk Factors; Syncope

2016